首页|Rades评分和Tomita评分在预测脊柱转移瘤患者预后的应用比较

Rades评分和Tomita评分在预测脊柱转移瘤患者预后的应用比较

扫码查看
目的 比较 Rades 评分和 Tomita 评分预测脊柱转移瘤患者临床预后的准确性.方法 回顾2010 年 1 月至 2020 年 12 月我院骨科收治的脊柱转移瘤住院患者 127 例,收集病历资料,随访至 2022 年 6 月30 日,计算 Rades 评分和 Tomita 评分,采用 Kaplan-Meier 法绘制生存曲线,Log-rank χ2 检验和 Cox 回归分析患者预后的影响因素.结果 患者中位生存时间为 10 个月,随访期内死亡占比 76.38%(97/127),6 个月和12 个月生存率分别为 69.29%和 27.56%.Rades 评分 20~30 分、31~35 分和≥36 分的患者平均生存时间分别为(7.0±2.6)、(11.7±2.3)和(17.7±4.7)个月,Tomita 评分 2~3 分、4~5 分、6~7 分和 8~9 分的患者生存时间分别为(18.5±4.7)、(11.9±2.2)、(8.4±3.0)和(5.5±1.5)个月.Rades 评分和 Tomita 评分预测患者生存时间的 ROC 曲线下面积分别为 0.931 和 0.928,最佳截断值为 36.5 和 4.5.Cox 回归显示:Rades 评分分级、原发肿瘤类型、治疗前能否自由活动、有无内脏转移和肿瘤诊断至脊柱转移时间是脊柱转移瘤预后的影响因素,Rades 评分 20~30 分和 31~35 分相对于≥36 分的 HR 分别为 41.871 和 4.728,肺癌和其它癌症相对于骨髓瘤/淋巴瘤的 HR 分别为 10.039 和 8.475,治疗前能自由活动的 HR 为 0.703,无内脏转移的 HR为 0.606,肿瘤诊断至发生脊柱转移时间>15 个月的 HR 为 0.496(P 均<0.05).Tomita 评分和 KPS 评分与患者生存时间有关,Tomita 评分 4~5 分、6~7 分和 8~9 分(相比于 2~3 分)的 HR 分别为 8.506、25.284 和84.590,KPS 评分 50~70 分和≥80 分(相比于≤40 分)的 HR 分别为 0.226 和 0.129.结论 脊柱转移瘤患者预后差,Rades评分和 Tomita评分对预测患者预后有一定价值,可作为治疗方式选择的参考依据.
Comparison of Rades score and Tomita score in predicting the prognosis of patients with spinal metastasis
Objective To compare the accuracy of Rades score and Tomita score in predicting the clinical prognosis of patients with spinal metastases.Methods A total of 127 patients with spinal metastases admitted to the Department of Orthopaedics of the First People's Hospital of Yibin from January 2010 to December 2020 were reviewed.Their medical records were collected and followed up to June 30,2022.Rades score and Tomita score were calculated.Kaplan-Meier method was used to draw the survival curve.Log-rank test and Cox regression were used to analyze the factors affecting the prognosis of patients.Results The median survival time of the patients was 10 months,with a mortality rate of 76.38%(97/127)during the follow-up period.The 6-month and 12-month survival rates were 69.29%and 27.56%,respectively.The average survival time of patients with Rades scores of 20 to 30,31 to 35,and≥36 was(7.0±2.6),(11.7±2.3),and(17.7±4.7)months,respectively.The survival time of patients with Tomita scores of 2 to 3,4 to 5,6 to 7,and 8 to 9 was(18.5±4.7),(11.9±2.2),(8.4±3.0),and(5.5±1.5)months,respectively.The area under the receiver operating characteristic curve predicted by Rades score and Tomita score was 0.931 and 0.928,respectively,with the best cut-off values at 36.5 and 4.5.Cox regression showed that the Rades score,primary tumor type,freedom of movement before treatment,presence or absence of visceral metastasis,and time from tumor diagnosis to spinal metastasis were influencing factors for the prognosis of spinal metastasis.The Rades scores of 20 to 30 and 31 to 35(compared to Rades score≥36)were 41.871 and 4.728,respectively.The HR of lung cancer and other cancers relative to myeloma/lymphoma was 10.039 and 8.475,respectively,and the HR of freedom of movement before treatment was 0.703.The HR without visceral metastasis was 0.606,and the HR for tumors diagnosed with spinal metastasis>15 months was 0.496(P<0.05).The Tomita score and KPS score were related to survival time of patients.The HR for Tomita scores of 4 to 5,6 to 7,and 8 to 9(compared to 2 to 3)were 8.506,25.284,and 84.590,respectively.The HR for KPS scores of 50 to 70 and≥80(compared to≤40)were 0.226 and 0.129,respectively.Conclusions Patients with spinal metastasis have poor prognosis,and the Rades score and Tomita score have certain value in predicting patient prognosis,which can serve as a reference to select treatment methods.

Neoplasm MetastasisSpinePrognosisForecastingRades scoreTomita score

王雅玲、张睿、彭国霖、蒋欣廷、张玉容

展开 >

644000 四川省,宜宾市第一人民医院骨科

肿瘤转移 脊柱 预后 预测 Rades评分 Tomita评分

四川省卫生计生委科研项目

18PJ572

2024

中国骨与关节杂志
中国医疗保健国际交流促进会,北京中科康辰骨关节伤病研究所

中国骨与关节杂志

CSTPCD
影响因子:0.665
ISSN:2095-252X
年,卷(期):2024.13(3)
  • 23